Dr Esther Mukuka, director of research inclusion at the NIHR, which supported the study, added: “Addressing the impact of G6PD deficiency on diabetes testing is an important step towards reducing inequalities and making sure that everyone, regardless of background, benefits equally from medical advances.”
